Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,794.00
Bid: 6,778.00
Ask: 6,780.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.03%)
Open: 6,886.00
High: 6,919.00
Low: 6,736.00
Yest. Close: 6,880.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Normality could return in summer 2021 if vaccine succeeds - UK health minister

LONDON, Sept 21 (Reuters) - Britain could return to pre-lockdown normal by next summer if a vaccine succeeds and was rolled out in the early part of 2021, health minister Matt Hancock said on Monday, adding that the most vulnerable might be vacci...

21 Sep 20 10:35

TOP NEWS: Astra's Lynparza Gets EU Ok For Ovarian And Prostate Cancer

TOP NEWS: Astra's Lynparza Gets EU Ok For Ovarian And Prostate Cancer

21 Sep 20 09:30

AstraZeneca's Tagriso trial shows 'meaningful improvement', Lynparza recommended for EU marketing

(Sharecast News) - Pharmaceutical giant AstraZeneca issued updates on the status of several drug candidates early on Monday.

21 Sep 20 08:36

UPDATE 2-EU agency recommends AstraZeneca-Merck drug Lynparza for two cancers

(Adds context, background on rival treatments)By Aakash B and Pushkala AripakaSept 21 (Reuters) - The European Medicines Agency (EMA) has recommended approval for Lynparza in patients with a form of prostate cancer and as a first-line maintenance t...

21 Sep 20 07:51

LONDON MARKET PRE-OPEN: Lower Start Seen; Informa Posts Interim Loss

LONDON MARKET PRE-OPEN: Lower Start Seen; Informa Posts Interim Loss

21 Sep 20 07:50

UPDATE 1-EU seals 2nd COVID-19 vaccine deal as deadline for WHO-led scheme looms

(Adds detail, background)BRUSSELS, Sept 18 (Reuters) - The European Union has agreed to buy a potential COVID-19 vaccine from Sanofi and GSK in its second such deal to secure supplies, as a deadline for signing up to the World Health Organization'...

18 Sep 20 10:51

UPDATE 2-EU seals 2nd COVID-19 vaccine deal as deadline for WHO scheme looms

* Sanofi, GSK to supply up to 300 mln shots* Deal comes on deadline day to join WHO's COVAX scheme* Many wealthy countries still to join (Adds detail, background)By Philip Blenkinsop and Matthias BlamontBRUSSELS/PARIS, Sept 18 (Reuters) - The Europe...

18 Sep 20 10:51

UPDATE 3-EU seals second COVID-19 vaccine deal as WHO scheme deadline looms

* Sanofi, GSK to supply up to 300 mln shots* Deal comes on deadline day to join WHO's COVAX scheme* Many wealthy countries still to join (Adds details, context)By Philip Blenkinsop and Matthias BlamontBRUSSELS/PARIS, Sept 18 (Reuters) - The European...

18 Sep 20 10:51

UPDATE 4-EU pays $384 mln for Sanofi-GSK COVID vaccine as WHO scheme deadline looms

* Sanofi, GSK to supply up to 300 mln shots* EU paid 324 million euros to secure supply* Deal comes on deadline day to join WHO's COVAX scheme* Many wealthy countries still to join (Adds price paid for deal in second paragraph)By Philip Blenkinsop a...

18 Sep 20 10:51

TOP NEWS: Positive Results For AstraZeneca Drugs Imfinzi And Lynparza

TOP NEWS: Positive Results For AstraZeneca Drugs Imfinzi And Lynparza

18 Sep 20 09:21

LIVE MARKETS-Closing snapshot: lower for longer blues, retail hymn

* European shares open lower: STOXX down 0.6%* Fed fails to cheer investors* BoE briefed on negative rates* Unibail-Rodamco drops on capital strengthening move Welcome to the home for real-time coverage of European equity markets brought to you by R...

17 Sep 20 16:59

LIVE MARKETS-Death and (corporate) taxes

* European shares open lower: STOXX down 0.6%* Fed fails to cheer investors* BoE briefed on negative rates* Unibail-Rodamco drops on capital strengthening move Welcome to the home for real-time coverage of European equity markets brought to you by R...

17 Sep 20 16:03

Illness in phase three trial not linked to Covid-19 vaccine, Oxford says

(Sharecast News) - The Covid19 vaccine being trialled by AstraZeneca and the University of Oxford was likely not behind the symptoms of one participant which led to the pause in the phase three trials last week, documents provided to the volunteers show.

17 Sep 20 12:50

LIVE MARKETS-Food delivery: appetite for M&A

* European shares open lower: STOXX down 0.6%* Fed fails cheer investors* BoE in focus, no change expected* Unibail-Rodamco drops on capital strengthening move Welcome to the home for real-time coverage of European equity markets brought to you by R...

17 Sep 20 11:14

LIVE MARKETS-Tight lending standards no longer doomsday for high yield bonds

* European shares open lower: STOXX down 0.6%* Fed fails cheer investors* BoE in focus, no change expected* Unibail-Rodamco drops on capital strengthening move Welcome to the home for real-time coverage of European equity markets brought to you by R...

17 Sep 20 10:55

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.